BIS Quality Control Amendment Order Regarding ABS (Acrylonitrile-Butadiene Styrene)

Introduction to the BIS QCO for ABS

The Ministry of Chemicals and Fertilizers had earlier notified the Acrylonitrile-Butadiene Styrene (ABS) Moulding and Extrusion Materials (Quality Control) Order, 2021, making BIS compliance mandatory for ABS materials that are mainly used in manufacturing applications.

Subsequently, the Ministry has issued a Quality Control Amendment Order introducing a specific product-based exemption under the existing QCO framework.

Key Changes You Should Know

1. The amendment clarifies that the ABS Quality Control Order, 2021, shall not apply to:
   1. Acrylonitrile-Butadiene Styrene (ABS) Moulding and Extrusion Materials
   2. Used specifically for the production of Toco Transducers.
2. This exemption is application-specific, not an exclusion for all ABS materials.
3. All other uses of ABS materials continue to remain covered under the existing QCO, unless otherwise notified by the BIS. 

What is the Date of Implementation?

• The amendment is effective from the date of its publication.
• The exemption applies immediately for eligible manufacturers who are producing toco transducers.

Now, What Should Businesses Do?

Manufacturers who are using ABS materials should carefully assess the end-use application of their products. If ABS moulding and extrusion materials are being used exclusively for the production of toco transducers, they may now avail an exemption from BIS certification under the ABS QCO.

However, businesses must ensure:

• Proper documentation of end-use.
• Clear traceability of ABS material usage.
• Readiness to demonstrate compliance during audits or inspections.

For manufacturers who are dealing with multiple product applications or seeking clarity on whether their ABS usage qualifies for exemption, Brand Liaison provides expert guidance on QCO applicability assessment, BIS exemption evaluation, documentation strategy, as well as complete regulatory liaison, ensuring accurate compliance without regulatory risk.